These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 423704)

  • 21. The effect of EGYT-475 (Trelibet) and its metabolites on the potassium-stimulated 3H-noradrenaline release from cortical slices of rat brain.
    Szücks Z; Szentendrei T; Fekete MI
    Pol J Pharmacol Pharm; 1987; 39(2):185-93. PubMed ID: 3432167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selectivity of release of norepinephrine, dopamine and 5-hydroxytryptamine by amphetamine in various regions of rat brain.
    Azzaro AJ; Rutledge CO
    Biochem Pharmacol; 1973 Nov; 22(22):2801-13. PubMed ID: 4761552
    [No Abstract]   [Full Text] [Related]  

  • 23. Neomycin inhibits K+- and veratridine-stimulated noradrenaline release in rat brain slices and rat brain synaptosomes.
    Diamant S; Avraham B; Atlas D
    FEBS Lett; 1987 Jul; 219(2):445-50. PubMed ID: 3609302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Similar potency ratios of amphetamine optical isomers for inhibition of dopamine uptake by synaptosomes of corpus striatum, olfactory tubercle and prefrontal cortex of the rat.
    Matthews RT; Shore PA
    Biochem Pharmacol; 1984 Sep; 33(17):2817-9. PubMed ID: 6466390
    [No Abstract]   [Full Text] [Related]  

  • 25. Specificity of amphetamine induced release of norepinephrine and serotonin from rat brain in vitro.
    Ziance RJ
    Res Commun Chem Pathol Pharmacol; 1977 Dec; 18(4):627-44. PubMed ID: 928960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic clonidine induces functional down-regulation of presynaptic alpha 2-adrenoceptors regulating [3H]noradrenaline and [3H]5-hydroxytryptamine release in the rat brain.
    Maura G; Bonanno G; Raiteri M
    Eur J Pharmacol; 1985 May; 112(1):105-10. PubMed ID: 2990964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nicotine-induced release of noradrenaline from hypothalamic synaptosomes.
    Yoshida K; Kato Y; Imura H
    Brain Res; 1980 Jan; 182(2):361-8. PubMed ID: 7357390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of metabolic inhibitors and ouabain on amphetamine- and potassium-induced release of biogenic amines from isolated brain tissue.
    Rutledge CO
    Biochem Pharmacol; 1978 Feb; 27(4):511-6. PubMed ID: 629810
    [No Abstract]   [Full Text] [Related]  

  • 29. Alpha-2 adrenergic inhibition of Ca(++)-evoked [3H]norepinephrine release from synaptosomes is blocked by depolarization.
    Bowyer JF; Weiner N
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1063-9. PubMed ID: 1972747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postnatal development of presynaptic alpha-adrenoceptors in rat cerebral cortex: studies with brain slices and synaptosomes.
    Wemer J; Mulder AH
    Brain Res; 1981 Mar; 208(2):299-309. PubMed ID: 6260286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal by amphetamine of the protective effect of bretylium on reserpine-induced depletion of noradrenaline.
    Chang CC
    J Pharm Pharmacol; 1965 Dec; 17(12):818-20. PubMed ID: 4379763
    [No Abstract]   [Full Text] [Related]  

  • 32. Regulation of catecholamine synthesis in rat brain synaptosomes.
    Patrick RL; Barchas JD
    J Neurochem; 1974 Jul; 23(1):7-15. PubMed ID: 4153038
    [No Abstract]   [Full Text] [Related]  

  • 33. Structure activity correlations in the inhibition of brain synaptosomal 3H-norepinephrine uptake by phenethylamine analogs. The role of alpha-alkyl side chain and methoxyl ring substitutions.
    Makriyannis A; Bowerman D; Sze PY; Fournier D; de Jong AP
    Eur J Pharmacol; 1982 Jul; 81(2):337-40. PubMed ID: 7117379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [3H]Dopamine release by d-amphetamine from striatal synaptosomes of reserpinized rats.
    Masuoka DT; Alcaraz AF; Schott HF
    Biochem Pharmacol; 1982 Jun; 31(11):1969-74. PubMed ID: 7115417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Release of endogenous norepinephrine and dopamine from rat brain regions in vitro.
    Kant GJ; Meyerhoff JL
    Life Sci; 1978 Nov; 23(21):2111-7. PubMed ID: 723467
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of d-amphetamine and potassium on serotonin release and metabolism in rat cerebral cortex tissue.
    Homan HD; Ziance RJ
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):223-40. PubMed ID: 6164082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional evidence for two stereochemically different alpha-2 adrenoceptors regulating central norepinephrine and serotonin release.
    Raiteri M; Maura G; Versace P
    J Pharmacol Exp Ther; 1983 Mar; 224(3):679-84. PubMed ID: 6298406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [3H]dopamine depletion from osmotically defined storage sites: effects of reserpine, 53 mM KCl, and d-amphetamine.
    Takimoto GS; Stittsworth JD; Stephens JK
    J Neurochem; 1983 Jul; 41(1):119-27. PubMed ID: 6864214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the effects of amphetamine and its metabolites, p-hydroxyamphetamine and p-hydroxynorephedrine, on uptake, release and catabolism of 3H-norepinephrine in cerebral cortex of rat brain.
    Wenger GR; Rutledge CO
    J Pharmacol Exp Ther; 1974 Jun; 189(3):725-32. PubMed ID: 4152317
    [No Abstract]   [Full Text] [Related]  

  • 40. Angiotensin II inhibits the K+-evoked release of [3H]norepinephrine from hypothalamic synaptosomes of the spontaneously hypertensive rat.
    Bottiglieri DF; Sumners C; Raizada MK
    Brain Res; 1987 Feb; 403(1):167-71. PubMed ID: 3828811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.